Sign in

CIK 0000921114 · Non-accelerated filer<br>Smaller reporting company

Armata Pharmaceuticals, Inc.

Sign in to watch
Ticker
ARMP
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
911549568
Phone
310-665-2928
Business address
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
Former names
AmpliPhi Biosciences Corp, TARGETED GENETICS CORP /WA/
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 70,000 shares (grant or award)
  7. 4 Grant or award Director acquired 50,000 shares (grant or award)
  8. 4 Shares withheld for taxes Vice President and CFO gave up 66,125 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 99,187 shares (to pay taxes)
  10. 4 Open-market sale 10% owner sold 875,000 shares at an average $0.26 ($227,398)
  11. 4 Open-market sale 10% owner sold 1,320,481 shares at an average $0.27 ($357,551)
  12. 4 Open-market sale 10% owner sold 160,000 shares at an average $0.51 ($81,626)
  13. 4 Open-market sale 10% owner sold 146,452 shares at an average $0.05 ($7,378)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 14 · 267 filings